Albuquerque, NM, July 25, 2017 -- Associa Canyon Gate will be hosting the “Board Success: The Power of Positive Relationships” seminar from 6-8PM CT on August 16, 2017. The session will focus on creating positive relationships within your community, especially from the standpoint of a HOA member.
Associa notes it is important to maintain a productive and professional relationship with residents and volunteer board members. This seminar will help establish and maintain valuable service levels with everyone serving your community. The information provided will equip you with the resources, skills and training you need to meet the challenges facing your community. It’s a great opportunity to learn, ask questions and engage with the professionals who support your success. There will also be a legislative update from the recent session by John Krueger, vice president of government affairs at Associa.
The guest speaker:
Gregory S. Cagle – attorney and author - Cagle Carpenter Hazlewood
Mr. Cagle will be discussing board member roles and responsibilities. Mr. Cagle is the managing partner of Cagle Carpenter Hazlewood and concentrates his law practice in civil and complex litigation involving real estate, nonprofit and for-profit corporations, business disputes, construction defects, and residential and commercial community associations. He has extensive litigation experience and has served as lead trial attorney in hundreds of trials in front of judges and juries.
In addition, Mr. Cagle is the author of “Texas Homeowners Association Law,” the only comprehensive legal reference manual on the state and federal laws governing Texas community association. He also has the distinguished honor of membership in the Community Associations Institute’s College of Community Association Lawyers, an organization whose membership consists of attorneys who have demonstrated skill, experience and high standards of professional and ethical conduct in the practice of community association law.
The event will be held at the Country Inn & Suites by Carlson in El Paso, Texas.
To attend, please RSVP to Leslie Lucero at [email protected].
With more than 180 branch offices across North America, Associa delivers unsurpassed management and lifestyle services to nearly five million residents worldwide. Our 10,000+ team members lead the industry with unrivaled education, expertise and trailblazing innovation. For more than 40 years, Associa has provided solutions designed to help communities achieve their vision. To learn more, visit www.associaonline.com.
Stay Connected:
Like us on Facebook: https://www.facebook.com/associa
Subscribe to the Blog: https://hub.associaonline.com/
Follow us on Twitter: https://twitter.com/associa
Join us on LinkedIn: http://www.linkedin.com/company/associa
|
|||
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/84f4cc66-91c3-4675-a30b-987ccebd5896
Ashley S Cantwell Associa 214-272-4107 [email protected]


Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FDA Approves Mitapivat for Anemia in Thalassemia Patients
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



